[1] 张力伟, 王忠诚. 脑干胶质瘤治疗现状[J]. 中国微侵袭神经外科杂志, 2010, 15(4): 145-147.[2] 中华医学会神经外科学分会肿瘤学组, 脑干胶质瘤综合诊疗中国专家共识编写委员会. 脑干胶质瘤综合诊疗中国专家共识[J]. 中华神经外科杂志, 2017, 33(3):217-229. [3] Fisher P G, Breiter S N, Carson B S, et al. A clinicopathologic reappraisal of brain stem tumor classification[J]. Cancer, 2000, 89(7):1569-1576.[4] Brown AP, Thompson BG, Spetzler RF. The two point method: evaluating brainstem lesions[J]. BNI Quarterly, 1996, 12(1):20-24.[5] 王忠诚, 张俊廷, 刘阿力. 311例脑干胶质瘤的临床特征与手术治疗[J]. 中国医学科学院学报, 2005, 27(1):7-12.[6] Laigle-Donadey F, Doz F, Delattre J Y. Brainstem gliomas in children and adults[J]. Current opinion in oncology, 2008, 20(6):662-667.[7] Mehta V S, Chandra P S, Singh P K, et al. Surgical considerations for 'intrinsic' brainstem gliomas: proposal of a modification in classification[J]. 中国神经肿瘤杂志, 2009, 7(3):166-166.[8] Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials[J]. Lancet Oncology, 2006, 7(3):241-248.[9] Bailey S, Howman, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy-Results of a United Kingdom phase II trial (CNS 2007 04)[J]. Eur J Cancer,2013,49(18):3856-3862.(本文由浙二神外周刊原创,浙江大学医学院附属第二医院神经外科徐佳鸣副主任医师、付再祥研究生整理,柳夫义、祝向东主任医师审校,张建民主任终审)